'Magic Mushrooms' Get FDA Green-Light to Treat Depression

'Magic Mushrooms' Get FDA Green-Light to Treat Depression Backed by
billionaire Peter Thiel, Psilocybin, aka "magic mushrooms," is a
psychedelic drug that has gained traction in
recent years as a possible treatment for depression. George Goldsmith,
co-founder Compass, via 'Daily Mail' Except for a brief time in the early 1960s, psilocybin has been illegal in the U.S. and is considered "fringe" by much of the mental health community. It's thought to work differently from antidepressants Standard antidepressants help prevent
overly negative emotions by regulating
the brain chemical serotonin. But the drugs reportedly
can leave patients feeling numbed. Psilocybin, on the other hand, seems to make the amygdala more responsive to emotions, while allowing patients to better process what they're feeling. This, in addition to psilocybin's reported "reset" of neural circuits — that create a negative feedback loop — seems to provide relief from depressive symptoms. George Goldsmith,
co-founder Compass, via 'Daily Mail'